It was found that SSRIs have the same efficacy at blocking SERT function and inducing AD-like effects in the middle-aged OVX rats tested 2 weeks, 4 months, or 8 months post-OVX (Figures 4 and 5). The gene discussed is SLC6A4; the disease is Alzheimer disease.